Ask VialBase
skin

Argireline

FDA: not-FDA-approved

Argireline is a topical peptide that mimics the N-terminal end of SNAP-25 to inhibit neurotransmitter release at the neuromuscular junction, reducing facial tension and minimizing dynamic wrinkles -- functioning as a milder, non-invasive alternative to Botox. Mimics the N-terminal end of SNAP-25, a protein involved in muscle contraction. Inhibits the release of neurotransmitters at the neuromuscular junction, reducing facial muscle tension. Minimizes the appearance of dynamic wrinkles (expression lines) (PMID: 23417317). Similar mechanism to botulinum toxin but milder and non-invasive. - Anti-wrinkle and skin smoothing - Dynamic wrinkle reduction (forehead, crow's feet) - Non-invasive Botox alternative - Cosmetic skin rejuvenation

This content is for educational and research purposes only. VialBase does not provide medical advice. Consult a healthcare professional before using any peptide.

Molecular weight —
Half-life —
CAS number 616204-22-9
Route —
02

Sourcing

Current prices

Updated today

200mg

Only vendor stocking this size on the VialBase roster.

Stocks this compound Third-party tested Public COAs

VialBase may earn a commission on purchases through partner links — never at additional cost to you. Full disclosure.

What bloodwork do I need?

Reference ranges are general guidelines. Consult your physician for interpretation.

PRE-CYCLE
  • CMP
  • CBC
DURING CYCLE
  • None required (topical only)
POST-CYCLE
  • None required
Safety & Regulatory Status
FDA STATUS not-FDA-approved

Regulatory status for Argireline may change. Verify current status with your jurisdiction before use. This is not legal or medical advice.

Frequently Asked Questions

What is Argireline?
Argireline is a topical peptide that mimics the N-terminal end of SNAP-25 to inhibit neurotransmitter release at the neuromuscular junction, reducing facial tension and minimi.
How does Argireline work?
Mimics the N-terminal end of SNAP-25, a protein involved in muscle contraction. Inhibits the release of neurotransmitters at the neuromuscular junction, reducing facial muscle tension.
How is Argireline dosed?
Standard: Applied topically at 5-10% concentration, 1-2 times daily; Route: Topical (creams, serums); Note: Works best as part of a broader skincare regimen. These figures reflect commonly cited research protocols, not medical advice — consult a clinician.
Is Argireline FDA-approved?
Argireline is not FDA-approved. Not FDA-approved as a drug; Available as a cosmetic ingredient in skincare products; Widely available over-the-counter in anti-aging serums.